These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17980049)

  • 1. Alternative methods of globotrioside production using Vero cells: a microcarrier system procedure.
    Miyagawa A; Kasuya MC; Hatanaka K
    Chem Cent J; 2007 Nov; 1():26. PubMed ID: 17980049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient sialylation on azidododecyl lactosides by using B16 melanoma cells.
    Murozuka Y; Kasuya MC; Kobayashi M; Watanabe Y; Sato T; Hatanaka K
    Chem Biodivers; 2005 Aug; 2(8):1063-78. PubMed ID: 17193190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification by centrifugal partition chromatography of amphiphilic compounds, glycolipids and pseudo-glycolipids synthesized by using cells.
    Kato T; Miyagawa A; Kasuya MC; Ito A; Hatanaka K
    J Chromatogr A; 2008 Jan; 1178(1-2):154-9. PubMed ID: 18082172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation of amphipathic lactoside primers with consequent inhibition of endogenous glycosphingolipid synthesis.
    Nakajima H; Miura Y; Yamagata T
    J Biochem; 1998 Jul; 124(1):148-56. PubMed ID: 9644257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin.
    Jacewicz MS; Mobassaleh M; Gross SK; Balasubramanian KA; Daniel PF; Raghavan S; McCluer RH; Keusch GT
    J Infect Dis; 1994 Mar; 169(3):538-46. PubMed ID: 8158025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
    Samuel JE; Perera LP; Ward S; O'Brien AD; Ginsburg V; Krivan HC
    Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.
    Boyd B; Tyrrell G; Maloney M; Gyles C; Brunton J; Lingwood C
    J Exp Med; 1993 Jun; 177(6):1745-53. PubMed ID: 8496689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of passage number on glycosylation of alkyl lactosides by Madin-Darby canine kidney (MDCK) cells.
    Shimura Y; Suzuki J; Kasuya MC; Matsuoka K; Hatanaka K
    J Biosci Bioeng; 2012 Nov; 114(5):552-5. PubMed ID: 22795668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing culture conditions for the production of animal cells in microcarrier culture.
    Clark JM; Hirtenstein MD
    Ann N Y Acad Sci; 1981; 369():33-46. PubMed ID: 6942784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Gb3 in lipid rafts in resistance to Shiga-like toxin of mutant Vero cells.
    Hanashima T; Miyake M; Yahiro K; Iwamaru Y; Ando A; Morinaga N; Noda M
    Microb Pathog; 2008 Aug; 45(2):124-33. PubMed ID: 18541402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stationary and microcarrier cell culture processes for propagating Japanese encephalitis virus.
    Wu SC; Huang GY
    Biotechnol Prog; 2002; 18(1):124-8. PubMed ID: 11822910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and poliovirus production of Vero cells on a novel microcarrier with artificial cell adhesive protein under serum-free conditions.
    Kurokawa M; Sato S
    J Biosci Bioeng; 2011 May; 111(5):600-4. PubMed ID: 21262586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of receptor-active, globotriaosyl ceramide/cholesterol lipid 'rafts' in vitro : A new assay to define factors affecting glycosphingolipid receptor activity.
    Nutikka A; Lingwood C
    Glycoconj J; 2004; 20(1):33-8. PubMed ID: 14973368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adamantyl globotriaosyl ceramide: a monovalent soluble mimic which inhibits verotoxin binding to its glycolipid receptor.
    Mylvaganam M; Lingwood CA
    Biochem Biophys Res Commun; 1999 Apr; 257(2):391-4. PubMed ID: 10198223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Globotriaosyl ceramide modulates interferon-alpha-induced growth inhibition and CD19 expression in Burkitt's lymphoma cells.
    Maloney MD; Binnington-Boyd B; Lingwood CA
    Glycoconj J; 1999 Dec; 16(12):821-8. PubMed ID: 11133022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Uses of Bacterial Subunit Toxins.
    Lingwood C
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verotoxin Receptor-Based Pathology and Therapies.
    Lingwood C
    Front Cell Infect Microbiol; 2020; 10():123. PubMed ID: 32296648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential changes in glycolipid expression during human B cell differentiation: enzymatic bases.
    Taga S; Tétaud C; Mangeney M; Tursz T; Wiels J
    Biochim Biophys Acta; 1995 Jan; 1254(1):56-65. PubMed ID: 7811747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation of lactosylceramide analogs in animal cells: amphipathic disaccharide primers for glycosphingolipid synthesis.
    Miura Y; Yamagata T
    Biochem Biophys Res Commun; 1997 Dec; 241(3):698-703. PubMed ID: 9434771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.